Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?

Data de publicació

2018-01-22T11:38:57Z

2018-01-22T11:38:57Z

2017-12-05

2018-01-22T11:38:57Z

Resum

The emergence of multi-drug resistant bacteria has undermined our capacity to control bacterial infectious diseases. Measures needed to tackle this problem include controlling the spread of antibiotic resistance, designing new antibiotics, and encouraging the use of alternative therapies. Phage therapy seems to be a feasible alternative to antibiotics, although there are still some concerns and legal issues to overcome before it can be implemented on a large scale. Here we highlight some of those concerns, especially those related to the ability of bacteriophages to transport bacterial DNA and, in particular, antibiotic resistance genes.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

MDPI

Documents relacionats

Reproducció del document publicat a: https://doi.org/10.3390/antibiotics6040032

Antibiotics, 2017, vol. 6, num. 32

https://doi.org/10.3390/antibiotics6040032

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

cc-by (c) Rodríguez Rubio,Lorena et al., 2017

http://creativecommons.org/licenses/by/3.0/es

Aquest element apareix en la col·lecció o col·leccions següent(s)